NasdaqGS - Nasdaq Real Time Price • USD
Natera, Inc. (NTRA)
As of 1:28 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 16 | 16 |
| Avg. Estimate | -0.69 | -0.64 | -2.47 | -1.19 |
| Low Estimate | -0.84 | -0.8 | -2.98 | -2.04 |
| High Estimate | -0.53 | -0.52 | -2.19 | -0.14 |
| Year Ago EPS | -0.97 | -0.95 | -3.78 | -2.47 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 16 | 16 |
| Avg. Estimate | 340.46M | 354.41M | 1.43B | 1.68B |
| Low Estimate | 321.6M | 336.31M | 1.33B | 1.52B |
| High Estimate | 350.3M | 362.73M | 1.45B | 1.91B |
| Year Ago Sales | 242.06M | -- | 1.08B | 1.43B |
| Sales Growth (year/est) | 40.70% | -- | 32.30% | 17.00% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.09 | -0.96 | -0.73 | -0.7 |
| EPS Actual | -0.97 | -0.95 | -0.64 | -0.56 |
| Difference | 0.12 | 0.01 | 0.09 | 0.14 |
| Surprise % | 11.00% | 1.00% | 12.30% | 20.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.69 | -0.64 | -2.47 | -1.19 |
| 7 Days Ago | -0.68 | -0.62 | -2.44 | -1.23 |
| 30 Days Ago | -0.62 | -0.55 | -2.32 | -1.2 |
| 60 Days Ago | -0.62 | -0.55 | -2.34 | -1.21 |
| 90 Days Ago | -0.7 | -0.64 | -2.62 | -1.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 3 | 7 |
| Up Last 30 Days | 2 | 1 | 4 | 9 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 12 | 13 | 12 | 6 |
Growth Estimates
| CURRENCY IN USD | NTRA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 28.90% | -- | -- | 8.00% |
| Next Qtr. | 32.60% | -- | -- | 12.40% |
| Current Year | 34.70% | -- | -- | 5.60% |
| Next Year | 51.80% | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 5/14/2024 |
| Maintains | BTIG: Buy to Buy | 5/13/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/10/2024 |
| Maintains | TD Cowen: Buy to Buy | 5/10/2024 |
| Maintains | Baird: Outperform to Outperform | 5/10/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 4/15/2024 |
Related Tickers
GH Guardant Health, Inc.
25.01
-1.38%
TWST Twist Bioscience Corporation
46.25
-1.62%
EXAS Exact Sciences Corporation
51.61
+2.43%
CDNA CareDx, Inc
15.59
+0.58%
ILMN Illumina, Inc.
109.89
-1.06%
MTD Mettler-Toledo International Inc.
1,526.44
+0.24%
DHR Danaher Corporation
266.85
+0.40%
WAT Waters Corporation
355.82
-0.04%
VCYT Veracyte, Inc.
22.43
-1.97%
IQV IQVIA Holdings Inc.
230.29
-0.38%